RFA-HL-26-012-Full-Announcement.html

This document is a Request for Application (RFA) for the Stimulating Access to Research in Residency (StARR) Program, a federal grant opportunity from the National Institutes of Health (NIH) involving multiple institutes: National Heart, Lung, and Blood Institute (NHLBI), National Institute of Allergy and Infectious Diseases (NIAID), National Institute on Aging (NIA), and National Eye Institute (NEI). The program aims to provide resident clinicians with in-depth research experiences to recruit, retain, and accelerate the independence of clinician-investigators capable of performing basic, clinical, and translational research.

The grant opportunity is associated with multiple federal grant programs, including Cardiovascular Diseases Research (CFDA 93.837), Allergy and Infectious Diseases Research (CFDA 93.855), Aging Research (CFDA 93.866), and Vision Research (CFDA 93.867). While the announcement indicates the funding opportunity is currently in a forecast stage and applications are not being solicited, potential applicants are encouraged to develop meaningful collaborations and responsive projects. The program will utilize the R38 activity code, and the grants will be evaluated based on scientific merit, investigator qualifications, research approach, and potential impact, with typical project periods spanning 1-5 years and award values potentially ranging from $35,000 to over $800,000.